Apellis Pharmaceuticals, Inc.
APLSDelisted May 14, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Apellis Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 284 | 2 | 302 | +20 |
| Shares | 113.8M | 78.3K | 113.1M | −619.3K (−0.5%) |
| Value | $6.82B | $4.69M | $6.65B | −$166.2M (−2.4%) |
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (66)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (46)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
Not filed for Q1 2024 yet (2)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Sawtooth Solutions, LLC | 78,246 | $4.68M |
| Coppell Advisory Solutions LLC | 79 | $4.73K |